Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys. BY MIHIR ZAVERI AND KATIE THOMAS your-feed-science, Drugs (Pharmaceuticals), Suits and Litigation (Civil), Fines (Penalties) October 9, 2019 at 07:17AM New York Times https://ift.tt/2p25dxC https://ift.tt/31YDhZP - Lets explore news - movie news,technology news,and more and more news of the world

Lets explore news - movie news,technology news,and more and more news of the world

this website provide news of all countries from all over the world.

    • Breaking

    Post Top Ad

    Responsive Ads Here

    Tuesday, October 8, 2019

    Home English News new york times news NYT Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys. BY MIHIR ZAVERI AND KATIE THOMAS your-feed-science, Drugs (Pharmaceuticals), Suits and Litigation (Civil), Fines (Penalties) October 9, 2019 at 07:17AM New York Times https://ift.tt/2p25dxC https://ift.tt/31YDhZP

    Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys. BY MIHIR ZAVERI AND KATIE THOMAS your-feed-science, Drugs (Pharmaceuticals), Suits and Litigation (Civil), Fines (Penalties) October 9, 2019 at 07:17AM New York Times https://ift.tt/2p25dxC https://ift.tt/31YDhZP


    By BY MIHIR ZAVERI AND KATIE THOMAS from NYT Health https://ift.tt/31YDhZP
    Tags
    Share This
    Author Image

    About Tech Tube By Lk

    Posted by at
    Labels: , , ,

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)